Related Experiment Video
Updated: Sep 4, 2025
06:53
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
2.9K
[Translated article] Oligometastases in oncological orthopaedic surgery. Our experience
E J Ortiz-Cruz1, C García-Mauriño Peñín2, D J Moriel-Garceso2
1Servicio de Cirugía Ortopédica y Traumatología, Hospital MD Anderson Cancer Center Madrid, Madrid, Spain; Servicio de Cirugía Ortopédica y Traumatología, Hospital Universitario La Paz, Madrid, Spain.
Revista Espanola De Cirugia Ortopedica Y Traumatologia
|July 17, 2022
Summary
This study found that patients with oligometastases treated at expert sarcoma centers had a 53% survival rate. Breast cancer patients showed over 70% survival, highlighting the importance of specialized care for bone metastases.
Area of Science:
- Oncology
- Surgical Oncology
- Cancer Metastasis
Background:
- Oligometastases represent an intermediate state between localized cancer and widespread metastatic disease.
- Effective management strategies for oligometastases are crucial for improving patient outcomes.
- Multidisciplinary approaches are increasingly recognized as vital in complex cancer care.
Purpose of the Study:
- To analyze the incidence and survival rates of patients with oligometastases.
- To evaluate the impact of expert multidisciplinary treatment centers on patient outcomes for sarcoma.
- To assess survival in patients with solitary or limited (normal) bone metastases.
Main Methods:
- Retrospective analysis of 414 patients with bone metastases from carcinomas.
- Inclusion of 28 patients meeting solitary or oligometastases criteria (excluding pelvis and axial skeleton).
- Kaplan-Meier method used for survival estimation.
Main Results:
- Overall survival for patients meeting oligometastases criteria was 53%.
- Breast cancer was the most common primary tumor, with survival exceeding 70%.
- The average patient age was 58 years.
Conclusions:
- Systemic treatments have improved disease-free survival, shifting the paradigm for oligometastases management.
- Treatment for oligometastases should be centralized in expert sarcoma treatment centers.
- Surgical treatment decisions for oligometastases require evaluation by multidisciplinary teams, considering prognosis, location, and histology.
